These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25922564)

  • 1. Efficacy of anakinra for various types of crystal-induced arthritis in complex hospitalized patients: a case series and review of the literature.
    Aouba A; Deshayes S; Frenzel L; Decottignies A; Pressiat C; Bienvenu B; Boue F; Damaj G; Hermine O; Georgin-Lavialle S
    Mediators Inflamm; 2015; 2015():792173. PubMed ID: 25922564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute gouty arthritis in complex hospitalized patients with anakinra.
    Ghosh P; Cho M; Rawat G; Simkin PA; Gardner GC
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1381-4. PubMed ID: 23650178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases.
    Ottaviani S; Moltó A; Ea HK; Neveu S; Gill G; Brunier L; Palazzo E; Meyer O; Richette P; Bardin T; Allanore Y; Lioté F; Dougados M; Dieudé P
    Arthritis Res Ther; 2013; 15(5):R123. PubMed ID: 24432362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis.
    Moltó A; Ea HK; Richette P; Bardin T; Lioté F
    Joint Bone Spine; 2012 Dec; 79(6):621-3. PubMed ID: 22658375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Anakinra in Acute Crystalline Diseases: A Retrospective Study Comparing a University Hospital with a Veterans Affairs Medical Center.
    Desmarais J; Chu CQ
    J Rheumatol; 2019 Jul; 46(7):748-750. PubMed ID: 30442822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
    Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
    Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Anakinra in Hospitalized Patients with Crystal-associated Arthritis.
    Liew JW; Gardner GC
    J Rheumatol; 2019 Oct; 46(10):1345-1349. PubMed ID: 30647192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases.
    Thomas M; Forien M; Palazzo E; Dieudé P; Ottaviani S
    Clin Rheumatol; 2019 Feb; 38(2):425-430. PubMed ID: 30145636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anakinra for the treatment of acute severe gout in critically ill patients.
    Thueringer JT; Doll NK; Gertner E
    Semin Arthritis Rheum; 2015 Aug; 45(1):81-5. PubMed ID: 25795473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
    Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
    Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature.
    Ottaviani S; Brunier L; Sibilia J; Maurier F; Ardizzone M; Wendling D; Gill G; Palazzo E; Meyer O; Dieudé P
    Joint Bone Spine; 2013 Mar; 80(2):178-82. PubMed ID: 23022422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure.
    Announ N; Palmer G; Guerne PA; Gabay C
    Joint Bone Spine; 2009 Jul; 76(4):424-6. PubMed ID: 19289295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases.
    Avram A; Duarte C; Santos MJ; Papagoras C; Ritis K; Scarpioni R; Schmidt WA; Skendros P
    Joint Bone Spine; 2015 Oct; 82 Suppl 1():eS17-29. PubMed ID: 26717798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
    Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
    Nigrovic PA; Mannion M; Prince FH; Zeft A; Rabinovich CE; van Rossum MA; Cortis E; Pardeo M; Miettunen PM; Janow G; Birmingham J; Eggebeen A; Janssen E; Shulman AI; Son MB; Hong S; Jones K; Ilowite NT; Cron RQ; Higgins GC
    Arthritis Rheum; 2011 Feb; 63(2):545-55. PubMed ID: 21280009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.
    Cronstein BN; Sunkureddi P
    J Clin Rheumatol; 2013 Jan; 19(1):19-29. PubMed ID: 23319019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.
    Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M
    J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field.
    Wortmann RL
    Curr Rheumatol Rep; 2004 Jun; 6(3):235-9. PubMed ID: 15134604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.